Shots:

• Coloplast to acquire Atos Medical for an enterprise value of $2.49B from PAI Partners. The transaction is expected to close in Q2'22
• Coloplast obtains access to a new chronic care segment to be run as a separate strategic business unit operating on shared Coloplast infrastructure that also supports its offerings in urology, continence and wound care
• Additionally, the combined entity will generate operational synergies by utilizing Coloplast infrastructure. Atos Medical focusses to improve the lives of patients from both laryngectomy and tracheostomy procedures

  Ref: Globe Newswire | Image: Logodix